EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease

被引：106

作者：

Marchesini G.

Day C.P.

Dufour J.-F.

Canbay A.

Nobili V.

Ratziu V.

Tilg H.

Roden M.

Gastaldelli A.

Yki-Järvinen H.

Schick F.

Vettor R.

Frühbeck G.

Mathus-Vliegen L.

机构：

[1] EASL Off, 7 Rue Daulain, CH-1203 Geneva, Switzerland

来源：

OBESITY FACTS | 2016年 / 9卷 / 02期

关键词：

HEPATIC INSULIN-RESISTANCE; PLACEBO-CONTROLLED TRIAL; CARDIOMETABOLIC RISK-FACTORS; RANDOMIZED CONTROLLED-TRIAL; TYPE-2; DIABETIC-PATIENTS; LIFE-STYLE MODIFICATION; VITAMIN-E; CARDIOVASCULAR-DISEASE; STIFFNESS MEASUREMENT; URSODEOXYCHOLIC ACID;

D O I：

10.1159/000443344

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

[No abstract available]

引用

页码：65 / 90

页数：26

共 149 条

[1]

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies [J].

Adams, LA ;

Sanderson, S ;

Lindor, KD ;

Angulo, P .

JOURNAL OF HEPATOLOGY, 2005, 42 (01) :132-138

[2]

Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis [J].

Aithal, Guruprasad P. ;

Thomas, James A. ;

Kaye, Philip V. ;

Lawson, Adam ;

Ryder, Stephen D. ;

Spendlove, Ian ;

Austin, Andrew S. ;

Freeman, Jan G. ;

Morgan, Linda ;

Weeber, Jonathan .

GASTROENTEROLOGY, 2008, 135 (04) :1176-1184

[3]

Review article: chronic hepatitis C - natural history and cofactors [J].

Alberti, A ;

Vario, A ;

Ferrari, A ;

Pistis, R .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 :74-78

[4]

Development and validation of a new histological score for pediatric non-alcoholic fatty liver disease [J].

Alkhouri, Naim ;

De Vito, Rita ;

Alisi, Anna ;

Yerian, Lisa ;

Lopez, Rocio ;

Feldstein, Ariel E. ;

Nobili, Valerio .

JOURNAL OF HEPATOLOGY, 2012, 57 (06) :1312-1318

[5]

Standards of Medical Care in Diabetes-2014 [J].

不详 .

DIABETES CARE, 2014, 37 :S14-S80

[6]

Effects of insulin treatment in type 2 diabetic patients on intracellular lipid content in liver and skeletal muscle [J].

Anderwald, C ;

Bernroider, E ;

Krssák, M ;

Stingl, H ;

Brehm, A ;

Bischof, MG ;

Nowotny, P ;

Roden, M ;

Waldhäusl, W .

DIABETES, 2002, 51 (10) :3025-3032

[7]

[Anonymous], 2015, J HEPATOL, V63, P237, DOI 10.1016/j.jhep.2015.04.006

[8]

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis [J].

Anstee, Quentin M. ;

Targher, Giovanni ;

Day, Christopher P. .

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2013, 10 (06) :330-344

[9]

Effects of n-3 fish oil on metabolic and histological parameters in NASH: A double-blind, randomized, placebo-controlled trial [J].

Argo, Curtis K. ;

Patrie, James T. ;

Lackner, Carolin ;

Henry, Thomas D. ;

de lange, Eduard E. ;

Weltman, Arthur L. ;

Shah, Neeral L. ;

Al-Osaimi, Abdullah M. ;

Pramoonjago, Patcharin ;

Jayakumar, Saumya ;

Binder, Lukas P. ;

Simmons-Egolf, Winsor D. ;

Burks, Sandra G. ;

Bao, Yongde ;

Taylor, Ann Gill ;

Rodriguez, Jessica ;

Caldwell, Stephen H. .

JOURNAL OF HEPATOLOGY, 2015, 62 (01) :190-197

[10]

Extrahepatic Complications of Nonalcoholic Fatty Liver Disease [J].

Armstrong, Matthew J. ;

Adams, Leon A. ;

Canbay, Ali ;

Syn, Wing-Kin .

HEPATOLOGY, 2014, 59 (03) :1174-1197

← 1 2 3 4 5 6 7 8 9 10 →